Industry news that matters to you.  Learn more

Targos Molecular Pathology GmbH and WuXi PharmaTech to Collaborate in Clinical Biomarker Services and Pathology Training in China

Targos GmbH, a leader in clinical biomarker services, and WuXi PharmaTech (NYSE:WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, recently announced a strategic biomarker collaboration.

Forest Laboratories Joins ConvergeHEALTH by Deloitte’s Rapid Learning Network in Collaboration with Intermountain Healthcare to Support Insights into Optimal Patient Care

ConvergeHEALTH by Deloitte is announcing that Forest Laboratories, Inc. (NYSE:FRX), a leading, fully integrated, specialty pharmaceutical company, and Intermountain Healthcare have entered into a multi-year collaboration to conduct outcomes research leveraging a next generation platform for generating insights into what works for patients. The initial focus of the collaboration is on respiratory disease.

NeuroVive Pharmaceutical and A1M Pharma Initiate Research Collaboration

NeuroVive Pharmaceutical AB (publ) (STO:NVP) and A1M Pharma AB (publ) have announced that the two companies are initiating a research collaboration in mitochondrial medicine. The partnership is governed by a collaboration agreement signed on 21 March 2014.

WuXi PharmaTech and Pacific Biomarkers Announce Collaboration

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D services company with operations in China and the United States, and Pacific Biomarkers (PBI), a premier biomarker laboratory services provider based in Seattle, recently announced a biomarker collaboration.

Boehringer Ingelheim and Duke Clinical Research Institute Form Collaborative Partnership to Study the Natural History of Idiopathic Pulmonary Fibrosis (IPF)

Boehringer Ingelheim Pharmaceuticals, Inc. and Duke Clinical Research Institute (DCRI) have formed a unique collaborative relationship to uncover insights into idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease.